Invention Grant
US08183213B2 Combination therapy comprising glucose reabsorption inhibitors and retinoid-X receptor modulators
有权
包含葡萄糖再吸收抑制剂和类视色素-X受体调节剂的组合疗法
- Patent Title: Combination therapy comprising glucose reabsorption inhibitors and retinoid-X receptor modulators
- Patent Title (中): 包含葡萄糖再吸收抑制剂和类视色素-X受体调节剂的组合疗法
-
Application No.: US11923187Application Date: 2007-10-24
-
Publication No.: US08183213B2Publication Date: 2012-05-22
- Inventor: Jacqueline C. Bussolari , Xiaoli Chen , Bruce R. Conway , Keith T. Demarest , Hamish N. M. Ross , Rafael Severino
- Applicant: Jacqueline C. Bussolari , Xiaoli Chen , Bruce R. Conway , Keith T. Demarest , Hamish N. M. Ross , Rafael Severino
- Applicant Address: US NJ Raritan
- Assignee: Ortho McNeil Pharmaceutical, Inc.
- Current Assignee: Ortho McNeil Pharmaceutical, Inc.
- Current Assignee Address: US NJ Raritan
- Main IPC: A61K31/70
- IPC: A61K31/70 ; A61K31/425 ; A61K31/35 ; A61K31/335
Abstract:
Combination therapy comprising RXR modulators and glucose reabsorption inhibitors useful for the treatment of diabetes and Syndrome X are disclosed.
Public/Granted literature
- US20090075864A1 COMBINATION THERAPY COMPRISING GLUCOSE REABSORPTION INHIBITORS AND RETINOID-X RECEPTOR MODULATORS Public/Granted day:2009-03-19
Information query
